These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 28592717)
1. Hypomethylated Ubiquitin-Conjugating Enzyme2 Q1 (UBE2Q1) Gene Promoter in the Serum Is a Promising Biomarker for Hepatitis B Virus-Associated Hepatocellular Carcinoma. Hu N; Fan XP; Fan YC; Chen LY; Qiao CY; Han LY; Wang K Tohoku J Exp Med; 2017 Jun; 242(2):93-100. PubMed ID: 28592717 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic Value of the Hypomethylation of the WISP1 Promoter in Patients with Hepatocellular Carcinoma Associated with Hepatitis B Virus. Chen LM; Xiang L; Sun WJ; Zhai YJ; Gao S; Fan YC; Wang K Tohoku J Exp Med; 2020 Dec; 252(4):297-307. PubMed ID: 33239483 [TBL] [Abstract][Full Text] [Related]
3. Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma. Yang Y; Fan YC; Gao S; Dou CY; Zhang JJ; Sun FK; Wang K Tohoku J Exp Med; 2014 Mar; 232(3):187-94. PubMed ID: 24646840 [TBL] [Abstract][Full Text] [Related]
4. Serum SOX11 promoter methylation is a novel biomarker for the diagnosis of Hepatitis B virus-related hepatocellular carcinoma. Teng Y; Fan YC; Mu NN; Zhao J; Sun FK; Wang K Neoplasma; 2016; 63(3):419-26. PubMed ID: 26925788 [TBL] [Abstract][Full Text] [Related]
5. Aberrant DNA methylation of G-protein-coupled bile acid receptor Gpbar1 (TGR5) is a potential biomarker for hepatitis B Virus associated hepatocellular carcinoma. Han LY; Fan YC; Mu NN; Gao S; Li F; Ji XF; Dou CY; Wang K Int J Med Sci; 2014; 11(2):164-71. PubMed ID: 24465162 [TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma suppressor 1 promoter hypermethylation in serum. A diagnostic and prognostic study in hepatitis B. Tian MM; Fan YC; Zhao J; Gao S; Zhao ZH; Chen LY; Wang K Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):171-180. PubMed ID: 28189396 [TBL] [Abstract][Full Text] [Related]
7. Exportin 4 gene expression and DNA promoter methylation status in chronic hepatitis B virus infection. Zhang F; Fan YC; Mu NN; Zhao J; Sun FK; Zhao ZH; Gao S; Wang K J Viral Hepat; 2014 Apr; 21(4):241-50. PubMed ID: 24597692 [TBL] [Abstract][Full Text] [Related]
8. Hypomethylation of the cyclin D1 promoter in hepatitis B virus-associated hepatocellular carcinoma. Liu HH; Fang Y; Wang JW; Yuan XD; Fan YC; Gao S; Han LY; Wang K Medicine (Baltimore); 2020 May; 99(20):e20326. PubMed ID: 32443384 [TBL] [Abstract][Full Text] [Related]
9. Combination of serum RASSF1A methylation and AFP is a promising non-invasive biomarker for HCC patient with chronic HBV infection. Dong X; He H; Zhang W; Yu D; Wang X; Chen Y Diagn Pathol; 2015 Aug; 10():133. PubMed ID: 26238200 [TBL] [Abstract][Full Text] [Related]
10. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA. Zhu C; Song H; Shen B; Wu L; Liu F; Liu X Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172 [TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation of UBE2Q1 promoter is associated with poor prognosis of acute-on-chronic hepatitis B pre-liver failure. Hu N; Xie XC; Liu LL; Lai WD Medicine (Baltimore); 2021 May; 100(21):e26066. PubMed ID: 34032735 [TBL] [Abstract][Full Text] [Related]
12. Combined use of murine double minute-2 promoter methylation and serum AFP improves diagnostic efficiency in hepatitis B virus-related hepatocellular carcinoma. Wang JW; Qian Y; Wu CS; Zhao NH; Fang Y; Yuan XD; Gao S; Fan YC; Wang K Int J Med Sci; 2020; 17(18):3190-3199. PubMed ID: 33173438 [No Abstract] [Full Text] [Related]
13. Methylation of serum insulin-like growth factor-binding protein 7 promoter in hepatitis B virus-associated hepatocellular carcinoma. Li F; Fan YC; Gao S; Sun FK; Yang Y; Wang K Genes Chromosomes Cancer; 2014 Jan; 53(1):90-7. PubMed ID: 24142767 [TBL] [Abstract][Full Text] [Related]
14. Hypomethylation of glycine dehydrogenase promoter in peripheral blood mononuclear cells is a new diagnostic marker of hepatitis B virus-associated hepatocellular carcinoma. Miao LL; Wang JW; Liu HH; Gao S; Fan YC; Wang K Hepatobiliary Pancreat Dis Int; 2024 Feb; 23(1):35-42. PubMed ID: 36878837 [TBL] [Abstract][Full Text] [Related]
15. Sera DNA Methylation of CDH1, DNMT3b and ESR1 Promoters as Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma. Dou CY; Fan YC; Cao CJ; Yang Y; Wang K Dig Dis Sci; 2016 Apr; 61(4):1130-8. PubMed ID: 26660680 [TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of secreted frizzled related protein 2 gene promoter serves as a noninvasive biomarker for HBV-associated hepatocellular carcinoma. Xiang L; Chen LM; Zhai YJ; Sun WJ; Yang JR; Fan YC; Wang K Life Sci; 2021 Apr; 270():119061. PubMed ID: 33454364 [TBL] [Abstract][Full Text] [Related]
17. Expression of IL-17 and its gene promoter methylation status are associated with the progression of chronic hepatitis B virus infection. Tian CH; Dai J; Zhang W; Liu Y; Yang Y Medicine (Baltimore); 2019 Jun; 98(23):e15924. PubMed ID: 31169710 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic Value of the Methylation of Multiple Gene Promoters in Serum in Hepatitis B Virus-Related Hepatocellular Carcinoma. Dong X; Hou Q; Chen Y; Wang X Dis Markers; 2017; 2017():2929381. PubMed ID: 28951629 [TBL] [Abstract][Full Text] [Related]
19. Measurement of Cyclin D2 (CCND2) Gene Promoter Methylation in Plasma and Peripheral Blood Mononuclear Cells and Alpha-Fetoprotein Levels in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma. Qian Y; Wang JW; Fang Y; Yuan XD; Fan YC; Gao S; Wang K Med Sci Monit; 2020 Dec; 26():e927444. PubMed ID: 33320844 [TBL] [Abstract][Full Text] [Related]
20. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma. Yu F; Lu Z; Chen B; Dong P; Zheng J Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]